Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

ClinicalTrials.gov ID: NCT04148391

Public ClinicalTrials.gov record NCT04148391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia

Study identification

NCT ID
NCT04148391
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aptinyx
Industry
Enrollment
99 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2019 (Actual)
Primary completion
Dec 30, 2022 (Estimated)
Completion
Dec 30, 2022 (Estimated)
Last update posted
Oct 27, 2022

2019 – 2022

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Aptinyx Clinical Site Scottsdale Arizona 85258 —
Aptinyx Clinical Site Fresno California 93710 —
Aptinyx Clinical Site Simi Valley California 93065 —
Aptinyx Clinical Site Boca Raton Florida 33486 —
Aptinyx Clinical Site Bradenton Florida 34209 —
Aptinyx Clinical Site Miami Florida 33122 —
Aptinyx Clinical Site Miami Florida 33165 —
Aptinyx Clinical Site Miami Florida 33173 —
Aptinyx Clinical Site Miami Florida 33176 —
Aptinyx Clinical Site Miami Lakes Florida 33016 —
Aptinyx Clinical Site Orlando Florida 32819 —
Aptinyx Clinical Site Port Charlotte Florida 33980 —
Aptinyx Clinical Site Port Orange Florida 32127 —
Aptinyx Clinical Site Sunrise Florida 33351 —
Aptinyx Clinical Site Decatur Georgia 30030 —
Aptinyx Clinical Site Farmington Hills Michigan 48334 —
Aptinyx Clinical Site Golden Valley Minnesota 55427 —
Aptinyx Clinical Site Toms River New Jersey 08755 —
Aptinyx Clinical Site Poughkeepsie New York 12601 —
Aptinyx Clinical Site Asheville North Carolina 28806 —
Aptinyx Clinical Site Dayton Ohio 45459 —
Aptinyx Clinical Site Tulsa Oklahoma 74136 —
Aptinyx Clinical Site Round Rock Texas 78681 —
Aptinyx Clinical Site Sugar Land Texas 77478 —
Aptinyx Clinical Site Bellevue Washington 98007 —
Aptinyx Clinical Site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04148391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2022 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04148391 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →